NCT00151424View on ClinicalTrials.gov

Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947)

PHASE3CompletedINTERVENTIONAL
Enrollment

277

Participants

Timeline

Start Date

February 15, 2005

Primary Completion Date

January 6, 2006

Study Completion Date

February 6, 2006

Conditions
Schizophrenia
Interventions
DRUG

asenapine

Asenapine 5-10mgBID

DRUG

Placebo

Matched against asenapine and olanzapine

DRUG

Olanzapine

10-20 mg QD

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00151424 - Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947) | Biotech Hunter | Biotech Hunter